Targeting mTOR Pathways in Human Malignancies
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2766-2777
Author(s):
Angelica Fasolo and Cristiana Sessa
Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2811-2829
Author(s):
Maha Elnaggar, Elisa Giovannetti and Godefridus J. Peters
Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2830-2837
Author(s):
Michael Edward Werner, Michael Bonner Foote and Andrew Zhuang Wang
Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Journal:
Current Stem Cell Research & Therapy
Volume:
7
Page:
197-216
Author(s):
Daniela F. Quail, Meghan J. Taylor and Lynne-Marie Postovit
Importance of Kier-Hall Topological Indices in the QSAR of Anticancer Drug Design
Journal:
Current Computer-Aided Drug Design
Volume:
8
Page:
159-170
Author(s):
Sisir Nandi and Manish C. Bagchi
Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives
Journal:
Current Biotechnology
Volume:
1
Page:
175-183
Author(s):
Min Shen and Q. Ping Dou
The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
2652-2664
Author(s):
B.-F. Ruan and H.-L. Zhu
Role of Hsp70 in Cancer Growth and Survival
Journal:
Protein & Peptide Letters
Volume:
19
Page:
616-624
Author(s):
Marcus P.D. Hatfield and Sandor Lovas
Anti-Inflammatory Agents from Plants: Progress and Potential
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
2088-2103
Author(s):
M.C. Recio, I. Andujar and J.L. Rios
Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
2061-2087
Author(s):
B. Orlikova and M. Diederich